A Call to Action on Cryptogenic Stroke

Slides:

Advertisements

Similar presentations

Management of Atrial Fibrillation in Primary Care Dr Matthew Fay Westcliffe Medical Practice Shipley Westcliffe Cardiology Service.

Advertisements

Project Objective To enhance the system of care for atrial fibrillation that not only reduces system costs, but improves the experiences of both patients.

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.

Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.

ARISTOTLE Objectives Primary: test for noninferiority of apixaban, a novel oral direct factor Xa inhibitor, versus warfarin Secondary: test for superiority.

Northern England Strategic Clinical Network Conference 15 th May 2015 Stroke Update Elizabeth Morris Network Delivery Team Manager.

Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Priorities Identified

Addressing the Challenges in Primary and Secondary Stroke Prevention

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

Figure 1 Flow chart of study selection.

Huron Perth EMS Stroke Update

Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.

Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.

Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.

NOACs for Cancer-Associated Thrombosis:

Atrial Fibrillation & Stroke Prevention in the West Midlands

Anticoagulants in Interventional Cardiology:

Improving the Diagnosis and Treatment of Seizures in Long-term Care

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Challenges in the Diagnosis of MS: Physician and Nurse Perspectives

Access to NOAC Therapy:

Appropriate Stroke Prevention Strategies in Atrial Fibrillation

Nat. Rev. Cardiol. doi: /nrcardio

Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.

The Comprehensive Major Depressive Disorder Care Team

Organizational Culture in the Oncology Medical Home

Selecting NOACs for High-Risk Patients

What Does the Affordable Care Act Focus on Quality Mean for My Diabetes Practice?

Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.

HBV Infection: Some Sobering Facts

CVD Secondary Prevention plans within Thames Valley

HBV Care Models: Community Collaborations for Best Practices

Assessing the Risk for Stroke in Patients With Atrial Fibrillation

Time to Take Gout Seriously

Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.

Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:

Seizures in the Elderly: Treatment and Special Considerations

Access to NOAC Therapy:

What Does the Affordable Care Act Focus on Quality Mean for My Diabetes Practice?

Adherence in SPAF: Measures to Improve Care

Managing Depression is a Team Effort:

Battling Constipation

Atrial Fibrillation.

Taking the "Cryptogenic" Out of Cryptogenic Stroke

Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.

Talking With Your Patients About Excessive Sweating

Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population Paul D. Ziegler, John D. Rogers,

Managing Age-Related Clinical Issues in Hemophilia

Managing HF in Primary Care

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Transitional Care of Patients With Hepatic Encephalopathy

Improving Adherence to Antiplatelet Therapy After an ACS Event

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Taking the "Cryptogenic" Out of Cryptogenic Stroke

5 Good Minutes on Atrial Fibrillation-related Stroke

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

CVD Secondary Prevention plans within Thames Valley

Key Considerations in Diagnosing the Flu

A Pharmacist's Guide to Safety and Use of Immune Checkpoint Inhibitors

Real-World Data in Cardiology: Focus on Atrial Fibrillation

Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.

Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

Comprehensive Acne Management

Extraordinary Cases in Stroke Prevention

Navigating the Journey

Shared-Decision Making in Dyslipidemia

Presentation transcript:

A Call to Action on Cryptogenic Stroke

Agenda

Stroke in the United States: 2020 Goal

Cryptogenic Stroke

The Role of the Neurologist as Point Person

Cryptogenic Stroke

TOAST Criteria

Why Do We Need a Diagnosis?

What Tests Are Needed?

What Tests Are Needed? (cont)

Cryptogenic Stroke

Cryptogenic Stroke Is Atrial Fibrillation the Cause? CRYSTAL AF

It's All About the Team

Using Systems of Care to Close Treatment Gaps

Acute Interventions

Secondary Prevention

Taking the Unknown Out of Cryptogenic

A Check List for Eliminating the Unknown Cause for Cryptogenic Stroke

TOAST Criteria

Diagnosis

Other Considerations

CRYSTAL AF

Key Elements in Ensuring a Smooth Transition of Care to Cardiology

Healthcare Team

The Role of the PCP

Patient Education

Abbreviations